The FDA has approved a new seasonal fly vaccine from Moderna called mFLUSIVA.
The FDA has approved Moderna’s mRNA‑based flu vaccine, called mFlu, for adults 50 and older ahead of the upcoming flu season.
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA ...
FLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be ...
Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines ...
Researchers found the shot to be about 27% more effective than the standard flu shot ...
Moderna received FDA approval for its new mRNA-based flu shot for older adults after months of regulatory questioning.
The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to ...
The mFlusiva vaccine will soon be available for adults aged 50 and over.
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from ...
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the ...
WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results